In the mid-1990s, genomic sequencing techniques revealed a link between germline PVs in the tumor-suppressor genes BRCA1 and BRCA2 with breast and ovarian cancer [3, 4]. The gene discussed is BRCA1; the disease is ovarian carcinoma.